MANCINI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 750
EU - Europa 411
AS - Asia 161
SA - Sud America 31
AF - Africa 28
Totale 1.381
Nazione #
US - Stati Uniti d'America 748
IT - Italia 153
CN - Cina 52
SE - Svezia 51
SG - Singapore 42
UA - Ucraina 42
IE - Irlanda 37
RU - Federazione Russa 36
BR - Brasile 29
DE - Germania 22
TR - Turchia 21
HK - Hong Kong 20
FR - Francia 16
GB - Regno Unito 15
DK - Danimarca 14
MA - Marocco 14
FI - Finlandia 13
CI - Costa d'Avorio 11
KR - Corea 10
IN - India 8
NL - Olanda 4
UZ - Uzbekistan 4
ZA - Sudafrica 3
BE - Belgio 2
CH - Svizzera 2
JP - Giappone 2
CA - Canada 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
LV - Lettonia 1
NO - Norvegia 1
PS - Palestinian Territory 1
VN - Vietnam 1
Totale 1.381
Città #
Chandler 120
Des Moines 56
Ashburn 55
Fairfield 55
Jacksonville 45
Boardman 43
New York 38
Dublin 37
Centro 30
Wilmington 24
Houston 23
Seattle 23
Singapore 23
Woodbridge 22
Hong Kong 20
Cambridge 19
Marche 17
Redmond 17
Turin 16
Ancona 15
Lawrence 15
Princeton 15
Rome 14
Abidjan 11
Ann Arbor 11
San Diego 11
San Mateo 10
Moscow 9
Beijing 8
Guangzhou 8
The Dalles 8
Los Angeles 7
Civitanova Marche 5
Menlo Park 5
Milan 5
Washington 5
Dallas 4
London 4
Mumbai 4
Naples 4
Tashkent 4
Wuhan 4
Brasília 3
Chicago 3
Helsinki 3
Huskvarna 3
Porto 3
Brussels 2
Casoria 2
Chennai 2
Fano 2
Gwangju 2
Johannesburg 2
Kilburn 2
Norwalk 2
Palermo 2
Pune 2
Stockholm 2
São Paulo 2
Zurich 2
Alto Santo 1
Amsterdam 1
Athens 1
Balneário Camboriú 1
Brescia 1
Cedar Knolls 1
Changzhi 1
Charlotte 1
Chiaravalle 1
Chiswick 1
Chizhou 1
Curitiba 1
Gravataí 1
Group 1
Grumo Nevano 1
Hangzhou 1
Ho Chi Minh City 1
Hounslow 1
Ipatinga 1
Jesi 1
Jiaxing 1
Jinan 1
Jundiaí 1
Kagoya 1
Lages 1
Lanzhou 1
Leawood 1
Lequile 1
Lichtenburg 1
Lviv 1
Macerata 1
Manchester 1
Mariana 1
Medellín 1
Mogi Guaçu 1
Montreal 1
Nablus 1
Nanjing 1
New Bedfont 1
Ningbo 1
Totale 950
Nome #
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 131
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 129
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 117
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 114
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 101
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 101
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 98
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 95
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 87
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 84
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 84
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 77
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 73
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 57
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 56
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 27
Totale 1.431
Categoria #
all - tutte 7.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 0 0 0 0 0 6 23
2020/2021199 17 19 20 0 22 7 33 21 22 14 13 11
2021/2022163 6 28 9 6 5 7 20 10 2 15 22 33
2022/2023350 30 44 16 23 25 85 0 16 63 2 38 8
2023/2024197 27 7 10 18 21 67 6 3 0 7 2 29
2024/2025287 45 32 13 2 13 23 22 10 72 25 30 0
Totale 1.431